Evaluation of artemisinins for the treatment of acute myeloid leukemia-Reference-Cited by-同舟云学术

Evaluation of artemisinins for the treatment of acute myeloid leukemia

Published:2016-04-28 Issue:6 Volume:77 Page:1231-1243
ISSN:0344-5704
Container-title:Cancer Chemotherapy and Pharmacology
language:en
Short-container-title:Cancer Chemother Pharmacol

Author:

Drenberg Christina D.,Buaboonnam Jassada,Orwick Shelley J.,Hu Shuiying,Li Lie,Fan Yiping,Shelat Anang A.,Guy R. Kiplin,Rubnitz Jeffrey,Baker Sharyn D.

Funder

National Cancer Institute

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Cancer Research,Pharmacology,Toxicology,Oncology

Link

http://link.springer.com/content/pdf/10.1007/s00280-016-3038-2.pdf

Reference30 articles.

1. Ribeiro RC (2014) Advances in treatment of de-novo pediatric acute myeloid leukemia. Curr Opin Oncol 26(6):656–662. doi: 10.1097/CCO.0000000000000136

2. Ferrara F, Schiffer CA (2013) Acute myeloid leukaemia in adults. Lancet 381(9865):484–495. doi: 10.1016/S0140-6736(12)61727-9

3. Krishna S, Uhlemann AC, Haynes RK (2004) Artemisinins: mechanisms of action and potential for resistance. Drug Resist Updates 7(4–5):233–244. doi: 10.1016/j.drup.2004.07.001

4. Efferth T, Dunstan H, Sauerbrey A, Miyachi H, Chitambar CR (2001) The anti-malarial artesunate is also active against cancer. Int J Oncol 18(4):767–773

5. Fox JM, Moynihan JR, Posner GH, Brown P, Civin CI, Chen X (2014) Repurposing Artemisinins for treatment of acute leukemias [abstract]. In: Proceedings of the 105th Annual Meeting of the American Association for Cancer Research, 5–9 Apr 2014; San Diego, CA Philadelphia (PA): AACR; Cancer Res 2014; 74(19 Suppl):Abstract nr 818

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Double‐Layered Metal‐Organic‐Frameworks‐Based Microswimmers for Adaptive Dual‐Drug Anti‐Cancer Therapy Using Artemisinin‐Based Compounds;Advanced Intelligent Systems;2024-06-20

2. Antineoplastic Drug Synergy of Artesunate with Navitoclax in Models of High-Grade Serous Ovarian Cancer;Cancers;2024-03-28

3. Artesunate acts through cytochrome c to inhibit growth of pediatric AML cells;Scientific Reports;2023-12-16

4. Artesunate reverses cytarabine resistance in acute myeloid leukemia by blocking the JAK/STAT3 signaling;Hematology;2023-10-10

5. ART714 is a best-in-class antileukemic 2-carbon-linked dimeric artemisinin derivative;Cancer Chemotherapy and Pharmacology;2023-05-30